We are live on
!
Find out more
SCM
Silvant Capital Management Portfolio holdings
AUM
$2.89B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+3.61%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$779M
AUM Growth
–
Cap. Flow
+$800M
Cap. Flow
% of AUM
102.72%
Top 10 Holdings %
Top 10 Hldgs %
30.64%
Holding
341
New
341
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$44.4M |
| 2 |
Apple
AAPL
|
+$40.4M |
| 3 |
Amazon
AMZN
|
+$37.6M |
| 4 |
Visa
V
|
+$24.3M |
| 5 |
Meta Platforms (Facebook)
META
|
+$20.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.88% |
| 2 | Financials | 15.62% |
| 3 | Healthcare | 12.96% |
| 4 | Industrials | 12.03% |
| 5 | Communication Services | 11.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCPC
126
Balchem Corp
BCPC
$5.26B
| $454K | 0.06% |
+5,551
| New | +$437K |
|
127
Texas Roadhouse
TXRH
$13.7B
| $450K | 0.06% |
+7,787
| New | +$448K |
|
128
IBM
IBM
$213B
| $449K | 0.06% |
+3,059
| New | +$463K |
|
129
Chemed
CHE
$7.16B
| $434K | 0.06% |
+1,589
| New | +$421K |
|
130
Pegasystems
PEGA
$5.09B
| $434K | 0.06% |
+14,310
| New | +$387K |
|
|
CMD
131
DELISTED
Cantel Medical Corporation
CMD
| $429K | 0.06% |
+3,847
| New | +$431K |
|
|
ARRY
132
DELISTED
Array Biopharma Inc
ARRY
| $415K | 0.05% |
+25,426
| New | +$407K |
|
133
Rogers Corp
ROG
$2.09B
| $409K | 0.05% |
+3,424
| New | +$521K |
|
|
DENN
134
DELISTED
Denny's
DENN
| $399K | 0.05% |
+25,883
| New | +$389K |
|
135
Philip Morris
PM
$309B
| $394K | 0.05% |
+3,920
| New | +$408K |
|
136
Viasat
VSAT
$9.67B
| $388K | 0.05% |
+5,903
| New | +$431K |
|
137
Johnson & Johnson
JNJ
$640B
| $386K | 0.05% |
+3,015
| New | +$408K |
|
138
Sarepta Therapeutics
SRPT
$1.64B
| $385K | 0.05% |
+5,200
| New | +$347K |
|
|
VSM
139
DELISTED
Versum Materials, Inc.
VSM
| $384K | 0.05% |
+10,216
| New | +$389K |
|
140
Supernus Pharmaceuticals
SUPN
$2.7B
| $379K | 0.05% |
+8,271
| New | +$345K |
|
141
ExxonMobil
XOM
$650B
| $378K | 0.05% |
+5,063
| New | +$405K |
|
142
H.B. Fuller
FUL
$3B
| $373K | 0.05% |
+7,503
| New | +$389K |
|
143
Monolithic Power Systems
MPWR
$61.4B
| $373K | 0.05% |
+3,211
| New | +$381K |
|
144
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.45B
| $372K | 0.05% |
+12,961
| New | +$381K |
|
145
Quaker Houghton
KWR
$2.58B
| $369K | 0.05% |
+2,493
| New | +$378K |
|
146
Chevron
CVX
$382B
| $364K | 0.05% |
+3,191
| New | +$381K |
|
147
Insulet
PODD
$11.8B
| $364K | 0.05% |
+4,201
| New | +$326K |
|
|
BECN
148
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $357K | 0.05% |
+6,732
| New | +$387K |
|
149
Bio-Techne
TECH
$11.2B
| $348K | 0.04% |
+9,204
| New | +$325K |
|
|
LOXO
150
DELISTED
Loxo Oncology, Inc
LOXO
| $343K | 0.04% |
+2,975
| New | +$316K |
|
Similar funds
ZF
AG
NRCM
CWM
BAM
PFM
DMIC
LIP
Silvant Capital Management's Q1 2018 Portfolio in Review
Q1 2018 is the first quarter with a 13F filing on record for Silvant Capital Management, which disclosed 341 positions worth $779M. Its ten largest holdings account for 31% of the portfolio.
Its largest position is Microsoft: 485,036 shares worth $44.3M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, followed by Financials and Healthcare.
- Silvant Capital Management's largest Q1 2018 buy was Microsoft: 485,036 shares worth $44.3M.
- Silvant Capital Management's ten largest holdings make up 31% of its $779M portfolio in Q1 2018.
- Silvant Capital Management disclosed 341 positions in Q1 2018, its first 13F filing on record.
Based on Silvant Capital Management's 13F filing for Q1 2018, filed 9 May 2018.